As shown in Supplementary Fig. 29, the Cy5-BPY@HSA presented enhanced tumor accumulation, whereas Cy5-HSA showed systemic distribution in the whole body, which demonstrated the good tumor target efficacy of Cy5-BPY@HSA (the biodistribution in the body was discussed in Supplementary Note 4). The gene discussed is ALB; the disease is neoplasm.